| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |